Balanced Rock Investment Advisors LLC
Position in GILD — Gilead Sciences, Inc.
CIK 2011851
ROSLINDALE, MA
Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$630,436
-$60,699 QoQ
Shares Held
4,990
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
#1,275
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balanced Rock Investment Advisors LLC holds $1,918,103 across 5 Drug Manufacturers - General names. GILD ranks #1 (32.9% of the industry book) .
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $630,436 | 4,990 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $691,135 | 4,959 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $616,032 | 5,019 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $567,432 | 5,112 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $564,328 | 5,090 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $596,554 | 5,324 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $509,697 | 5,518 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $499,099 | 5,953 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $411,179 | 5,993 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $441,111 | 6,022 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $525,430 | 6,486 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||